Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
In vitro antimicrobial activity of five essential oils on multidrug resistant Gram-negative clinical isolates. β
Go to Publication β
Journal of intercultural ethnopharmacology (J Intercult Ethnopharmacol ) Vol: 5 Issue 3 Pages: 212-8 Pub: 2016 Jun-Aug Epub: 2016 May 30 Authors Sakkas H , Gousia P , Economou V , Sakkas V , Petsios S , Papadopoulou C , |
|
|
In vitro antimicrobial activity of five essential oils on multidrug resistant Gram-negative clinical isolates. β
Go to Publication β
Journal of intercultural ethnopharmacology (J Intercult Ethnopharmacol ) Vol: 5 Issue 3 Pages: 212-8 Pub: 2016 Jun-Aug Epub: 2016 May 30 Authors Sakkas H , Gousia P , Economou V , Sakkas V , Petsios S , Papadopoulou C , |
|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. β
Go to Publication β
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Inhibition of Fungal Strains Isolated from Cereal Grains via Vapor Phase of Essential Oils. β
Molecules (Basel, Switzerland) (Molecules ) Vol: 26 Issue 5 Pages: Pub: 2021 Mar 1 Epub: 2021 Mar 1 Authors Strelková T , Nemes B , Kovács A , Novotný D , Božik M , Kloucek P , |
|
|
Antioxidant, Anti-Inflammatory, and Microbial-Modulating Activities of Essential Oils: Implications in Colonic Pathophysiology. β
International journal of molecular sciences (Int J Mol Sci ) Vol: 21 Issue 11 Pages: Pub: 2020 Jun 10 Epub: 2020 Jun 10 Authors Spisni E , Petrocelli G , Imbesi V , Spigarelli R , Azzinnari D , Donati Sarti M , Campieri M , Valerii MC , |
|
|
The Influence of Essential Oils on Gut Microbial Profiles in Pigs. β
Go to Publication β
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 10 Issue 10 Pages: Pub: 2020 Sep 24 Epub: 2020 Sep 24 Authors Ruzauskas M , Bartkiene E , Stankevicius A , Bernatoniene J , Zadeike D , Lele V , Starkute V , Zavistanaviciute P , Grigas J , Zokaityte E , Pautienius A , Juodeikiene G , Jakstas V , |
|
|
Thyme (Thymus vulgaris L.) polyphenols ameliorate DSS-induced ulcerative colitis of mice by mitigating intestinal barrier damage, regulating gut microbiota, and suppressing TLR4/NF-?B-NLRP3 inflammasome pathways. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 2 Pages: 1113-1132 Pub: 2023 Jan 23 Epub: 2023 Jan 23 Authors Zhou Z , He W , Tian H , Zhan P , Liu J , |
|
|
Evidence for synergistic activity of plant-derived essential oils against fungal pathogens of food. β
Go to Publication β
Food microbiology (Food Microbiol ) Vol: 53 Issue Pt B Pages: 24-30 Pub: 2016 Feb Epub: 2015 Aug 18 Authors Hossain F , Follett P , Dang Vu K , Harich M , Salmieri S , Lacroix M , |
|
|
Inhibitory Effects of Endemic Thyme's Thymol-Carvacrol Chemotype Essential Oil on Aspergillus Species with Free Radical Scavenging Properties. β
Go to Publication β
Chemistry & biodiversity (Chem Biodivers ) Vol: 21 Issue 5 Pages: e202302115 Pub: 2024 May Epub: 2024 Apr 17 Authors Mirahmadi SF , Shayganfar A , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
